VivoSeq
Other

Extubation

0

Pipeline Programs

5

Active Trials

0

Companies Involved

Extubation is an early-stage landscape with 0 programs across 0 companies.

Pipeline Metrics

Competitive Density

19/100

Pipeline Velocity

6/100

Mech. Concentration

N/A

Completion Rate

80/100

Attrition Rate

9/100

Programs by Phase

No pipeline programs currently tracked for this disease.

Trial Status

11

clinical trials

Completed4 · 36%
Recruiting3 · 27%
Enrolling by invitation1 · 9%
Unknown status1 · 9%
Withdrawn1 · 9%
Not yet recruiting1 · 9%

Trial Activity

11 trials

Magnesium Sulphate and Extubation Quality
Completed··Phase 4·NCT05858957·98 enrolled
Beta-blocker Before Extubation
Withdrawn··N/A·NCT00563238

Data sources: ClinicalTrials.gov (NIH) · OpenFDA (FDA) · ChEMBL (EMBL-EBI) · Open Targets (EBI/Sanger) · MedlinePlus (NIH) · PubMed (NIH) · SEC EDGAR (SEC)